GLP1R Agonists and Precision Medicine: In Search of Predictive Biomarkers

被引:0
|
作者
Bagheri, Sayna [1 ]
Pilla, Scott J. [2 ,3 ,4 ]
Taylor, Simeon, I [5 ]
机构
[1] Univ Tehran Med Sci, Fac Med, Tehran 1416634793, Iran
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21287 USA
[5] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
来源
关键词
GLP1; GIP; tirzepatide; latent autoimmune diabetes of adults; glutamic acid decarboxylase autoantibodies; type; 2; diabetes; GIP; EFFICACY;
D O I
10.1210/clinem/dgae548
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e1272 / e1273
页数:2
相关论文
共 50 条
  • [31] Effect of GLP1R agonists taspoglutide and liraglutide on primary thyroid C-cells from rodent and man
    Boess, Franziska
    Bertinetti-Lapatki, Cristina
    Zoffmann, Sannah
    George, Catherine
    Pfister, Thomas
    Roth, Adrian
    Lee, Serene M. L.
    Thasler, Wolfgang E.
    Singer, Thomas
    Suter, Laura
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2013, 50 (03) : 325 - 336
  • [32] Modulation of Cardiorenal Benefits for GLP-1RAs Treatment by GLP1R Genetic Variants
    Xue, Qiaochu
    Li, Piaopiao
    Pasquel, Francisco J.
    Phillips, Lawrence S.
    Liang, Donghai
    Narayan, K. M. Venkat
    Umpierrez, Guillermo
    Ali, Mohammed K.
    Shao, Hui
    DIABETES, 2024, 73
  • [33] Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling
    Feetham, Claire H.
    Collabolletta, Valeria
    Worth, Amy A.
    Shoop, Rosemary
    Groom, Sam
    Harding, Court
    Boudjadja, Mehdi Boutagouga
    Coskun, Tamer
    Emmerson, Paul J.
    D'Agostino, Giuseppe
    Luckman, Simon M.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [34] GLP1R Regualtion of Gap Junction Coupling in the Islet of Langerhans
    Walter, Rachelle
    Farnsworth, Nikki
    Benninger, Richard
    FASEB JOURNAL, 2015, 29
  • [35] The Hypothalamic Glucagon-like Peptide-1 (Glp1) Receptor (Glp1r) Is Necessary for the Anorectic Effects of Endogenous Glp1 but Not of the Glp1r Agonist Exendin-4 (Ex4)
    Burmeister, Melissa A.
    Smouse, Hannah
    Landivar-Rocha, Adriana
    Ayala, Jennifer E.
    Stoffers, Doris A.
    Seeley, Randy J.
    Ayala, Julio E.
    DIABETES, 2014, 63 : A99 - A100
  • [36] Genetic Evidence for Repurposing of GLP1R (Glucagon-Like Peptide-1 Receptor) Agonists to Prevent Heart Failure
    Daghlas, Iyas
    Karhunen, Ville
    Ray, Devleena
    Zuber, Verena
    Burgess, Stephen
    Tsao, Philip S.
    Lynch, Julie A.
    Lee, Kyung Min
    Voight, Benjamin F.
    Chang, Kyong-Mi
    Baker, Emma H.
    Damrauer, Scott M.
    Howson, Joanna M. M.
    Vujkovic, Marijana
    Gill, Dipender
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (13):
  • [37] Contribution of SNV GLP1R in Diseasome of Metabolically Unhealthy Obesity
    Abaturov, Aleksandr
    Nikulina, Anna
    Nikulin, Dmytro
    Holikova, Anastasiia
    Dikhtyarenko, Daryna
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [38] Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats
    Li, De-juan
    Yue, Qin
    Liu, Lu
    Che, Ke-ke
    Liu, Xue-mei
    Hu, Chang-hua
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (08) : 1267 - 1279
  • [39] GLP-1R AGONISTS AND WEIGHT LOSS GLP-1R agonists are not a quick fix for weight loss
    Iverson, Kristen A.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [40] Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats
    De-juan Li
    Qin Yue
    Lu Liu
    Ke-ke Che
    Xue-mei Liu
    Chang-hua Hu
    Acta Pharmacologica Sinica, 2021, 42 : 1267 - 1279